Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms
about
Pharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genesAntipsychotic drug-induced movement disorders.Divergent long-term consequences of chronic treatment with haloperidol, risperidone, and bromocriptine on traumatic brain injury-induced cognitive deficitsEPR spectroscopy of chlorpromazine-induced free radical formation in normal human melanocytes.Reversal of reserpine-induced orofacial dyskinesia and catalepsy by Nardostachys jatamansi.Agmatine protection against chlorpromazine-induced forebrain cortex injury in rats.Crocin prevents haloperidol-induced orofacial dyskinesia: possible an antioxidant mechanismOxidative stress and the antipsychotic-induced vacuous chewing movement model of tardive dyskinesia: evidence for antioxidant-based prevention strategies.Combining the Antipsychotic Drug Haloperidol and Environmental Enrichment after Traumatic Brain Injury Is a Double-Edged Sword.The selective cyclooxygenase-2 inhibitor, the compound 11b improves haloperidol induced catatonia by enhancing the striatum dopaminergic neurotransmission.Effects of agmatine on chlorpromazine toxicity in the liver of Wistar rats: the possible role of oxidant/antioxidant imbalance.Nigella sativa Oil Reduces Extrapyramidal Symptoms (EPS)-Like Behavior in Haloperidol-Treated Rats.Protective effect of Morus alba leaves on haloperidol-induced orofacial dyskinesia and oxidative stress.Korean ginseng extract attenuates reserpine-induced orofacial dyskinesia and improves cognitive dysfunction in rats.Effects of carvedilol on delayed rectifier and transient inactivating potassium currents in rat hippocampal CA1 neurons.Effect of chronic treatment of carvedilol on oxidative stress in an intracerebroventricular streptozotocin induced model of dementia in rats.Support for association of HSPG2 with tardive dyskinesia in Caucasian populations.Reversal of haloperidol-induced orofacial dyskinesia by quercetin, a bioflavonoid.Attenuation of cyclosporine-induced renal dysfunction by catechin: possible antioxidant mechanism.Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory study.Neuroprotective effect of naphtha[1,2-d]thiazol-2-amine in an animal model of Parkinson's disease.Carvedilol alleviates testicular and spermatological damage induced by cisplatin in rats via modulation of oxidative stress and inflammation.Beneficial effect of candesartan and lisinopril against haloperidol-induced tardive dyskinesia in rat.
P2860
Q28088705-69EAA6B2-6873-4AAA-86F4-EA159EA095B0Q35105771-7D6D2C4A-7DA2-423D-AA96-93D6189F73ABQ35376749-51928BB6-E867-43E4-B42A-0280615243ADQ35730859-B1C9354B-14C2-45B6-ADCF-DDF033881512Q36021015-08FF17E7-9B1B-4DEB-ABE3-8B339D5E31EEQ36731453-DE4106EB-ED96-4AFE-AEBE-8592229E431EQ37416345-204D146A-0588-4463-9F81-DAADAC6056FAQ38206130-A2442418-02C4-4CEE-BF93-2FA1C69500CCQ39921323-7B669266-9AEB-4E39-96CC-DE44FABCE7CFQ42212454-7D51C507-CE5E-4A1B-8A94-F7AEAF54A8C8Q42322622-E9661D58-E784-4E9E-AD2F-DCFFF5F48D7AQ42500690-FC048266-D213-4386-8B68-2C1865A3CCDCQ42964570-924B5736-1D79-4A5A-86E5-0946911518B5Q42971036-75E8D003-2F3D-4A16-9435-AD592699BBDFQ42971780-A7B1AC24-5350-481E-94E7-3C21E10D4558Q43230724-DD5D6139-06C5-4323-AF64-5305E397B430Q44208517-3DEF2E51-A04B-4519-B924-722DCD220E15Q44386044-8E554544-8640-49CE-B818-520AADC0079FQ44629535-8A40EDE1-7D05-4282-A23E-BE82B1C10D47Q45007058-4FAB52DB-538C-4908-890A-66B5C6C20F5AQ46322181-1A94BC1E-D920-4BBE-A04A-B81E79D705C9Q48358702-4D69D957-854E-4E28-9EF8-C537930F6D39Q50693406-FD186EC4-D3F6-499F-92A8-28673313CCE6
P2860
Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Carvedilol attenuates neurolep ...... ossible antioxidant mechanisms
@en
type
label
Carvedilol attenuates neurolep ...... ossible antioxidant mechanisms
@en
prefLabel
Carvedilol attenuates neurolep ...... ossible antioxidant mechanisms
@en
P2093
P2860
P356
P1476
Carvedilol attenuates neurolep ...... ossible antioxidant mechanisms
@en
P2093
Amanpreet Singh
Pattipati S Naidu
Shrinivas K Kulkarni
P2860
P304
P356
10.1038/SJ.BJP.0704717
P407
P577
2002-05-01T00:00:00Z